Copy Link Print Information

GSK2837808A

52 Cited Publications
Revisión del cliente

Based on 52 publication(s) in Google Scholar

GSK2837808A is a potent and selective lactate dehydrogenase A (LDHA) inhibitor with IC50s of 2.6 and 43 nM for hLDHA and hLDHB, respectively.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.24%
  • No. CAS: 1445879-21-9
  • Fòrmula: C31H25F2N5O7S
  • Peso molecular:649.62
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • GSK2837808A Chemical Structure
    GSK2837808A Chemical Structure
  • Experimental Validation Results for GSK2837808A
  • Experimental Validation Results for GSK2837808A
  • Experimental Validation Results for GSK2837808A
  • Experimental Validation Results for GSK2837808A
  • Experimental Validation Results for GSK2837808A
No. CAS: 1445879-21-9
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of GSK2837808A:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) GSK2837808A

More
Customer Validation & Images
Cell Proliferation/Viability AssayFlow CytometryBio/Physico-chemical AssayWBCell Imaging/Staining
  • Flow Cytometry
  • Cell Imaging/Staining
  • WB
  • Cell Proliferation/Viability Assay
  • Bio/Physico-chemical Assay

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • GSK2837808A Chemical Structure
    GSK2837808A Chemical Structure
    1/16
  • 1/16

    GSK2837808A purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Apr 1;37(4):903-919.e10. [Abstract]

    Customer Validation
     FACS quantification of STAR-based CSC percentage in TPO3 and TPO4 treated with LDHA inhibitor GSK2837808A (GSK, 100 µM, 3 days).

  • 1/16

    GSK2837808A purchased from MedChemExpress. Usage Cited in: Gastroenterology. 2024 May;166(5):772-786.e14. [Abstract]

    Customer Validation
     Phase-contrast images of dysplastic organoids treated with dimethyl sulfoxide (DMSO; vehicle), GSK2837808A (LDH inhibitor; 10 μM), 6-aminonicotinamide (G6PD inhibitor; 50 μM), telaglenastat (GLS1 inhibitor; 1 μM) for 3 days.

  • 1/16

    GSK2837808A purchased from MedChemExpress. Usage Cited in: J Ethnopharmacol. 2023 May 23:308:116271. [Abstract]

    Customer Validation
     The conditioned media (CM) from hypoxia-treated NRK-52 E cells reduce the expression of FN, COL-Ⅰ, α-SMA and PCNA proteins in NRK-49 F cells after SSR (Shen Shuai II Recipe) and (or) GSK (GSK2837808A) treatment.

  • 1/16

    GSK2837808A purchased from MedChemExpress. Usage Cited in: Nat Commun. 2020 Jun 22;11(1):3162. [Abstract]

    Customer Validation
     Proliferation of HepG2 cells with HULC knockdown (left panel) or overexpression (right panel) was measured with a CCK8 assay. For rescue experiments, HepG2-HULC cells were treated by FGFR1 inhibitor PD 166866 (2.5 μM), PKM2 activator DASA-58 (30 μM), or LDHA inhibitor GSK2837808A (10 μM), respectively.

  • 1/16

    GSK2837808A purchased from MedChemExpress. Usage Cited in: Nat Commun. 2020 Jul 9;11(1):3427. [Abstract]

    Customer Validation
     Chondrocytes were treated with IL-1β (10 ng/mL) in the presence of GSK2837808A (10 μM), oxamate (10 mM) or FX11 (40 μM) for 24 hours for supernatant lactic acid measurement.

  • GSK2837808A